The DOI matches its Crossref record.
Adipose tissue, insulin action and vascular disease: inflammatory signals
Abstract
Insulin resistance, both in nondiabetic and diabetic subjects, is frequently associated with obesity, particularly an excess of central fat. Many of the features that have been ascribed to the metabolic or insulin-resistance syndrome are also more commonly found in obese subjects. These phenotypes include diabetic dyslipidaemia, elevation of levels of plasminogen activator inhibitor-1, microalbuminuria and endothelial dysfunction. More recently, features of acute-phase activation and low-grade inflammation, including elevated levels of fibrinogen, C-reactive protein and interleukin-6, have been associated with (central) obesity. Adipose tissue generation of cytokines has been shown in vitro and in vivo, and a number of novel cytokine-like molecules, collectively termed adipocytokines, have been identified as adipocyte products. While several of these, such as tumour necrosis factor-alpha, may act predominantly in autocrine or paracrine fashion, others are released into the systemic circulation, acting as signalling molecules to remote tissues, including liver, skeletal muscle and endothelium. A clearer understanding of adipose tissue signalling, and its contribution to the state of low-grade inflammation of obesity, will require physiological, as well as cellular and molecular, studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“past and emerging evidence indicates that chronic low-grade inflammation is associated with poor Fe status in obese persons (716 -721) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [717]
Citations
Cited by
Sorted by citations
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Adipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210
“…WAT is secreting factors that stimulate the production of inflammatory markers from the liver and other organs; this may well be the case with CRP, where it is argued that hepatic production is stimulated by increased IL-6 from the expanded fat mass of the obese (Yudkin et al. 2000; Yudkin, 2003).”
BackgroundDietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
Hypoxia and Adipose Tissue Function and Dysfunction in Obesity
Trayhurn, P. (2013) · Physiological Reviews · doi:10.1152/physrev.00017.2012 · Cited by 932
Vascular complications in diabetes mellitus: the role of endothelial dysfunction
Schalkwijk, C. G., & Stehouwer, C. D. A. (2005) · Clinical Science · doi:10.1042/cs20050025 · Cited by 670
Sarcopenic obesity and inflammation in the InCHIANTI study
Schrager, M. A., Metter, E. J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., & Ferrucci, L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2006 · Cited by 594
The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance
Goossens, G. H. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.10.010 · Cited by 591
“hepatic production of C-reactive protein [76,110,111].”
Signalling role of adipose tissue: adipokines and inflammation in obesity
Trayhurn, P., & Wood, I. S. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331078 · Cited by 634
Maternal obesity and fetal metabolic programming: a fertile epigenetic soil
Heerwagen, M. J. R., Miller, M. R., Barbour, L. A., & Friedman, J. E. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00310.2010 · Cited by 544
Endocrine and signalling role of adipose tissue: new perspectives on fat
Trayhurn, P. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2005.01468.x · Cited by 513
“C-reactive protein is synthesized mainly in the liver and it is evident that in obesity hepatic production and release is stimulated by IL-6 secreted from adipocytes (Yudkin et al. 2000, Yudkin 2003).”
BackgroundPrevalence and Trends of a Metabolic Syndrome Phenotype Among U.S. Adolescents, 1999–2000
Duncan, G. E., Li, S. M., & Zhou, X. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2438 · Cited by 495
Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation
Rodríguez-Hernández, H., Simental‐Mendía, L. E., Ramírez, G. R., & Reyes-Romero, M. A. (2013) · International Journal of Endocrinology · doi:10.1155/2013/678159 · Cited by 509
“[44] J.”
BackgroundHypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?
Trayhurn, P., Wang, B., & Wood, I. S. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508971282 · Cited by 464
“…through changes in the release of inflammation-related adipokines and the infiltration of macrophages (13,14) , is viewed as central to the development of the major obesity-associated diseases – the metabolic syndrome, type 2 diabetes, CVD and certain cancers (such as breast and colon) (5,10,15) .”
Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression
Jernås, M., Palming, J., Sjöholm, K., Jennische, E., Svensson, P.-A., Gabrielsson, B. G., Levin, M., Sjögren, A., Rudemo, M., Lystig, T. C., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5678fje · Cited by 454
The evolving role of inflammation in obesity and the metabolic syndrome
Lee, Y.-H., & Pratley, R. E. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0071-7 · Cited by 369
Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction
Sun, K., Park, J., Gupta, O. T., Holland, W. L., Auerbach, P., Zhang, N., Goncalves Marangoni, R., Nicoloro, S. M., Czech, M. P., Varga, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms4485 · Cited by 364
Yang, R., Lee, M., Hu, H., Pollin, T. I., Ryan, A. S., Nicklas, B. J., Snitker, S., Horenstein, R. B., Hull, K., Goldberg, N. H., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030287 · Cited by 354
“Increasing evidence supports the hypothesis that the lowgrade chronic systemic inflammation associated with obesity may be an important mediator of the metabolic syndrome and its constituents, including insulin resistance, type 2 diabetes, dyslipidemia, and hypertension [29–31].”
BackgroundAjuwon, K. M., & Spurlock, M. E. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00397.2004 · Cited by 358
“First, in addition to obesity and insulin resistance, chronic inflammation accompanies the prediabetic condition known as the metabolic syndrome (33).”
BackgroundFrom excess adiposity to insulin resistance: The role of free fatty acids
Capurso, C., & Capurso, A. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.05.003 · Cited by 337
“…led to the view that obese individuals are characterized by a state of chronic low-grade inflammation, and that this is causally linked to insulin resistance, hyperlipidemia and the MetS (Yudkin et al., 1999; Das, 2001; Festa et al., 2001; Hotamisligil, 2003; Yudkin, 2003; Trayhurn and Wood, 2004).”
BackgroundInfluentialMacrophage-secreted factors induce adipocyte inflammation and insulin resistance
Permana, P. A., Menge, C., & Reaven, P. D. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.012 · Cited by 307
Obesity and the lung: 5 {middle dot} Obesity and COPD
Franssen, F. M. E., O'Donnell, D. E., Goossens, G. H., Blaak, E. E., & Schols, A. M. W. J. (2008) · Thorax · doi:10.1136/thx.2007.086827 · Cited by 303
“77 78 Importantly, inflammatory pathways play a prominent role in the mechanisms underlying insulin resistance and type 2 diabetes in cultured cells and animal models, 79–81 and this may also be the case in humans.”
BackgroundMontani, J.-P., Carroll, J. F., Dwyer, T. M., Antic, V., Yang, Z., & Dulloo, A. G. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802858 · Cited by 294
“Obesity is being increasingly recognized as a low-grade inflammatory state.(36) Features of acute-phase activation and low-grade inflammation, including elevated circulating levels”
BackgroundCellular hypoxia and adipose tissue dysfunction in obesity
Wood, I. S., de Heredia, F. P., Wang, B., & Trayhurn, P. (2009) · Proceedings of The Nutrition Society · doi:10.1017/s0029665109990206 · Cited by 302
Scioli, M. G., Storti, G., D’Amico, F., Rodríguez Guzmán, R., Centofanti, F., Doldo, E., Céspedes Miranda, E. M., & Orlandi, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061995 · Cited by 281
Fat as an Endocrine Organ: Relationship to the Metabolic Syndrome
Hutley, L. J., & Prins, J. B. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00005 · Cited by 265
Bahçeci, M., Gökalp, D., Bahçeci, S., Tuzcu, A. K., Atmaca, S., & Arikan, S. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347427 · Cited by 266
Inflammation and metabolic dysfunction: links to cardiovascular diseases
Taube, A., Schlich, R., Sell, H., Eckardt, K., & Eckel, J. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00907.2011 · Cited by 246
“In this context, it has been shown that plasma levels of several proinflammatory cytokines as well as acute phase proteins such as C-reactive protein (CRP) are increased in obesity, contributing to a chronic state of low-grade inflammation (67, 326, 327).”
BackgroundSelective Inhibition of Hypoxia-Inducible Factor 1α Ameliorates Adipose Tissue Dysfunction
Sun, K., Halberg, N., Khan, M., Magalang, U. J., & Scherer, P. E. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00951-12 · Cited by 231
“The development of inflammation in adipose tissue has been linked to many other metabolic syndromes (55, 56).”
BackgroundTrayhurn, P., Drevon, C. A., & Eckel, J. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2010.535835 · Cited by 214
“The extent to which inflammation-related factors are secreted by adipocytes reflects the fact that adipose tissue exhibits an inflammatory response as tissue mass expands in obesity (Yudkin, 2003; Hotamisligil, 2006).”
BackgroundOmega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome
Martínez‐Fernández, L., Laiglesia, L. M., Huerta, A. E., Martínez, J. A., & Moreno-Aliaga, M. J. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.07.003 · Cited by 218
Vázquez, L. A., Pazos, F., de Berrazueta, J. R., Fernández-Escalante, C., García‐Unzueta, M. T., Freijanes, J., & Amado, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032059 · Cited by 205
“According to previous reports, elevation of both the acute phase mediators, CRP and SA, and the proinflammatory cytokines, TNF and IL-6, has characterized morbid obesity as a low grade inflammatory process of the innate immune system (39, 40).”
BackgroundMaternal Obesity, Inflammation, and Fetal Skeletal Muscle Development1
Du, ., Yan, X., Tong, J. F., Zhao, J., & Zhu, M. J. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.109.077099 · Cited by 214
Mechanisms of Obesity-Induced Gastrointestinal Neoplasia
Alemán, J. O., Eusebi, L. H., Ricciardiello, L., Patidar, K. R., Sanyal, A. J., & Holt, P. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.11.051 · Cited by 201
“Obesity Paradox” in Acute Respiratory Distress Syndrome: Asystematic Review and Meta-Analysis
Guo, Z., Xin, W., Wang, Y., Guohong, X., & Shu-ying, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163677 · Cited by 203
Paniagua, J. A. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i19.483 · Cited by 197
Mechanisms of endothelial dysfunction in obesity.
Avogaro, A., & de Kreutzenberg, S. V. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.04.020 · Cited by 188
Winer, J. C., Zern, T. L., Taksali, S. E., Dziura, J. D., Cali, A. M. G., Wollschlager, M., Seyal, A. A., Weiss, R., Burgert, T. S., & Caprio, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0733 · Cited by 183
IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes
Wood, I. S., Wang, B., & Trayhurn, P. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.081 · Cited by 187
The Effect of Obesity on Outcomes among Injured Patients
Byrnes, M. C., McDaniel, M. D., Moore, M. B., et al. (2005) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000152081.67588.10 · Cited by 176
The Association Between BMI and Plasma Cytokine Levels in Patients With Acute Lung Injury
Stapleton, R. D., Dixon, A. E., Parsons, P. E., Ware, L. B., & Suratt, B. T. (2010) · CHEST Journal · doi:10.1378/chest.10-0014 · Cited by 171
Koskinen, J. M., Kähönen, M. A. P., Viikari, J. S. A., Taittonen, L. M., Laitinen, T. P., Rönnemaa, T., Lehtimäki, T. J., Hutri‐Kähönen, N., Pietikäinen, M., Jokinen, E. V., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.845065 · Cited by 170
Trayhurn, P. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00316.x · Cited by 170
Wang, B., & Trayhurn, P. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0055-8 · Cited by 163
“These factors, which are generally termed adipokines, can act either in an autocrine/paracrine or endocrine manner, and changes in their production are increasingly considered to underlie the development of obesity-associated diseases such as type 2 diabetes and the metabolic syndrome [5, 30, 44].”
BackgroundBrunner, E. J., Mika Kivimaki, B., Witte, D. R., Lawlor, D. A., Smith, G. D., Cooper, J. A., Miller, M. A., Lowe, G. D. O., Rumley, A., Casas, J. P., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050155 · Cited by 162
“This cytokine and tumor necrosis factor (TNF)-a are candidate mediators for the proposed inflammatory link between increased body fat and induction of insulin resistance locally in adipocytes and in distant tissues [1,44,45].”
BackgroundParacrine role for periadventitial adipose tissue in the regulation of arterial tone
Gollasch, M., & Dubrovska, G. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.10.005 · Cited by 160
Li, R., Theriault, A., Au, K. K. W., Douglas, T. D., Casaschi, A., Kurowska, E. M., & Mukherjee, R. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.01.023 · Cited by 152
Mirza, M. S. (2011) · ISRN Gastroenterology · doi:10.5402/2011/592404 · Cited by 148
“The inflammatory state may be causal in the development of insulin resistance and the metabolic syndrome [72, 76].”
BackgroundObesity, metabolic syndrome and esophageal adenocarcinoma: Epidemiology, etiology and new targets
Ryan, A. M., Duong, M. T., Healy, L., Ryan, S. A., Parekh, N., Reynolds, J. V., & Power, D. G. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.03.001 · Cited by 151
“Obesity causes an overall pro-inflammatory state, which is recognised by elevated CRP levels, commonly present in centrally obese people [123].”
BackgroundDinh, W., Füth, R., Nickl, W., Krahn, T., Ellinghaus, P., Scheffold, T., Bansemir, L., Bufe, A., Barroso, M. C., & Lankisch, M. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-58 · Cited by 149
“There is increasing evidence that inflammation is involved in the pathophysiology of heart failure and diabetes [6-9].”
Interdisziplinäre Leitlinie der Qualität S3 zur „Prävention und Therapie der Adipositas”
Hauner, H., Moss, A., Berg, A., Bischoff, S. C., Colombo‐Benkmann, M., Ellrott, T., Heintze, C., Kanthak, U., Kunze, D., Stefan, N., et al. (2014) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/s-0037-1618857 · Cited by 139
“• Chronische Inflammation Einige Sekretionsprodukte des Fettgewebes weisen inflammatorische Eigenschaften auf, welche die Insulinwirkung beeinträchtigen und die Entwicklung von atherosklerotischen Prozessen begünstigen (34).”
BackgroundInfluentialRecombinant Leptin Promotes Atherosclerosis and Thrombosis in Apolipoprotein E–Deficient Mice
Bodary, P. F., Gu, S., Shen, Y., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000173306.47722.ec · Cited by 135
Inflammation, insulin resistance, and obesity
Ferroni, P., Basili, S., Falco, A., & Davı̀, G. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0082-x · Cited by 135
Obesity, Metabolic Syndrome, and Cardiovascular Disease
Aggoun, Y. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e31805d8a8c · Cited by 135
“It has been hypothesized that both insulin resistance and endothelial dysfunction have a common background, possibly via inflammatory mediators released from adipose tissue (32) or even a common risk factor in the perinatal period.”
BackgroundHypoxia and the endocrine and signalling role of white adipose tissue
Trayhurn, P., Wang, B., & Wood, I. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802306602 · Cited by 130
Jones, S. B., Thomas, G. A., Hesselsweet, S. D., Alvarez-Reeves, M., Yu, H., & Irwin, M. L. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0278 · Cited by 132
“IL-6 and CRP seem to bemore amenable to change through fat loss as compared with TNF-a perhaps because adipose tissue is a significant producer of IL-6, which in turn is a regulator of hepatic CRP synthesis (59), whereas themajority of adipocyte-produced TNF-a is sequestered and contributes a relatively small amount t…”
BackgroundHoppmann, J., Perwitz, N., Meier, B., Faßhauer, M., Hadaschik, D., Lehnert, H., & Klein, J. C. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0292 · Cited by 125
Adipose Tissue in Obesity—An Inflammatory Issue
Trayhurn, P. (2005) · Endocrinology · doi:10.1210/en.2004-1597 · Cited by 118
Reinehr, T., Stoffel‐Wagner, B., Roth, C. L., & Andler, W. (2005) · Metabolism · doi:10.1016/j.metabol.2005.03.022 · Cited by 119
Endothelial dysfunction: role in obesity-related disorders and the early origins of CVD
Singhal, A. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2004404 · Cited by 115
“Recent reviews have addressed the effect on endothelial function of the inter-related metabolic, biochemical and haematological factors associated with obesity (Williams et al. 2002; Yudkin, 2003).”
BackgroundMenstrual cycle symptoms are associated with changes in low‐grade inflammation
Puder, J. J., Blum, C. A., Müeller, B., Geyter, C. D., Dye, L., & Keller, U. B. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01591.x · Cited by 110
Obesity and Inflammation: Evidence for an Elementary Lesion
Sbarbati, A., Osculati, F., Silvagni, D., Benati, D., Galiè, M., Camoglio, F. S., Rigotti, G., & Maffeis, C. (2006) · Pediatrics · doi:10.1542/peds.2004-2854 · Cited by 106
Serum Amyloid A: A Marker of Adiposity‐induced Low‐grade Inflammation but Not of Metabolic Status
Poitou, C., Coussieu, C., Rouault, C., Coupaye, M., Cancello, R., Bedel, J., Gouillon, M., Bouillot, J., Oppert, J., Basdevant, A., et al. (2006) · Obesity · doi:10.1038/oby.2006.40 · Cited by 105
Malavazos, A., Corsi, M., Ermetici, F., Coman, C., Sardanelli, F., Rossi, A., Morricone, L., & Ambrosi, B. (2007) · NMCD. Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.01.001 · Cited by 105
Lakoski, S. G., Cushman, M., Siscovick, D. S., Blumenthal, R. S., Palmas, W., Burke, G. L., & Herrington, D. M. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.91 · Cited by 105
Impact of Gender and Menstrual Cycle Phase on Plasma Cytokine Concentrations
O’Brien, S. M., Fitzgerald, P., Scully, P., Landers, A., Scott, L. V., & Dinan, T. G. (2007) · NeuroImmunoModulation · doi:10.1159/000107423 · Cited by 109
Trayhurn, P. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2004406 · Cited by 106
“A key hypothesis is that adipose tissue-derived inflammatory factors may play a causal role in the development of the insulin-resistance and associated pathologies (the metabolic syndrome) of obesity (Hotamisligil, 2003; Yudkin, 2003).”
BackgroundEndothelial Dysfunction in Obesity: Role of Inflammation
Virdis, A. (2016) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-016-0133-8 · Cited by 103
“Growing literature indicates that PVAT plays a direct role in regulating low-grade inflammation also by secreting TNF-a and IL-6 [9].”
BackgroundMicrovascular Endothelial Dysfunction in Patients with Obesity
Virdis, A., Masi, S., Colucci, R., Chiriacò, M., Uliana, M., Puxeddu, I., Bernardini, N., Blandizzi, C., & Taddei, S. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0930-2 · Cited by 110
Obesity, Inflammation, and Vascular Disease
Calabrò, P., & Yeh, E. T. H. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5688-5_3 · Cited by 101
“[24, 25] While the general assumption is that inflammation is consequent to obesity, it has been suggested that obesity is in fact a result of inflammatory disease.”
BackgroundIncreased Rho Kinase Activity in a Taiwanese Population With Metabolic Syndrome
Liu, P., Chen, J.-H., Lin, L.-J., & Liao, J. K. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.043 · Cited by 99
Comorbidities and Systemic Effects of Chronic Obstructive Pulmonary Disease
Choudhury, G., Rabinovich, R., & MacNee, W. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.10.007 · Cited by 101
“Chronic low-grade inflammation is also a hallmark of obesity, insulin resistance, and type 2 diabetes.(166,167) Besides the presence of chronic airflow obstruction, low-grade systemic inflammation could therefore be one of the common mechanisms that may be responsible for the observed mortality and morbidity in obese…”
Polus, A., Zapała, B., Raźny, U., Gielicz, A., Kieć‐Wilk, B., Malczewska-Malec, M., Sanak, M., Childs, C. E., Calder, P. C., & Dembinska-Kiec, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.08.005 · Cited by 94
O’Brien, S. M., Scully, P., & Dinan, T. G. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.11.014 · Cited by 93
“Previous studies (Aldhahi and Hamdy, 2003; Yudkin, 2003) have found increased adipose tissue mass to be associated with overexpression of TNF-α, IL-6, and plasminogen activator inhibitor-1, and underexpression of adiponectin in adipose tissue.”
BackgroundSpousal Loss and Health in Late Life
Das, A. (2012) · Journal of Aging and Health · doi:10.1177/0898264312464498 · Cited by 89
“…(de Wit et al., 2010; Spitzer et al., 1993) as well as negative behaviors (diet, inactivity) to obesity (Mokdad et al., 2001), and documents the causal role of obesity in poor blood-sugar control, diabetes, and heart disease (Grundy, Brewer Jr., Cleeman, Smith Jr., Lenfant, 2004; Yudkin, 2003).”
BackgroundHow does race get “under the skin”?: Inflammation, weathering, and metabolic problems in late life
Das, A. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.11.007 · Cited by 93
“Consistent with this notion, an extensive literatures does link worse health behaviors (diet, inactivity) with obesity, and documents the causal role of obesity in blood-sugar control, diabetes, and heart disease (Grundy et al., 2004; Yudkin, 2003).”
BackgroundInfluentialAdipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease?
Calabrò, P., Golia, E., Maddaloni, V., Malvezzi, M., Casillo, B., Marotta, C., Calabrò, R., & Golino, P. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0207-2 · Cited by 86
“Second, white adipose tissue (WAT) is responsible for the production of factors that stimulate the production of inflammatory markers from the liver other organs; this may well be the case of CRP, where it is argued that hepatic and extra hepatic production are stimulated by increased IL-6 from the expanded fat mass o…”
BackgroundMicrovascular Endothelial Dysfunction in Human Obesity: Role of TNF-α
Virdis, A., Colucci, R., Bernardini, N., Blandizzi, C., Taddei, S., & Masi, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00512 · Cited by 89
“Moreover, leptin can stimulate the secretion of TNF-α and interleukin-6 (IL-6) which, in turn, may induce endothelial dysfunction (27).”
BackgroundInfluentialCalabrò, P., & Yeh, E. T. H. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0008-z · Cited by 84
Glucose-Free Dialysis Solutions: Inductors of Inflammation or Preservers of Peritoneal Membrane?
Martikainen, T., Teppo, A., Grönhagen‐Riska, C., et al. (2005) · Peritoneal Dialysis International · doi:10.1177/089686080502500509 · Cited by 83
“There are also other recent reports that assume features of low-grade inflammation may be associated with obesity (23,24).”
BackgroundRole of nutrition on anemia in elderly
Bianchi, V. E. (2015) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2015.09.003 · Cited by 85
Association of Midlife Inflammatory Markers With Cognitive Performance at 10-Year Follow-up
Kipinoinen, T., Toppala, S., Rinne, J. O., Viitanen, M. H., Jula, A., & Ekblad, L. L. (2022) · Neurology · doi:10.1212/wnl.0000000000201116 · Cited by 81
CCAAT/Enhancer Binding Proteinβin relation to ER Stress, Inflammation, and Metabolic Disturbances
van der Krieken, S. E., Popeijus, H. E., Mensink, R. P., & Plat, J. (2015) · BioMed Research International · doi:10.1155/2015/324815 · Cited by 81
“Typically, elevated concentrations of C-reactive protein, various cytokines, prothrombotic molecules, and adhesionmolecules are present in this inflammatory state [4– 6] which play an essential role in the development of atherosclerosis and insulin resistance [7, 8].”
BackgroundNordic Diet and Inflammation—A Review of Observational and Intervention Studies
Lankinen, M. A., Uusitupa, M. I. J., & Schwab, U. (2019) · Nutrients · doi:10.3390/nu11061369 · Cited by 87
Gastric Bypass and Sleeve Gastrectomy: the Same Impact on IL-6 and TNF-α. Prospective Clinical Trial
Viana, E. C., Araujo-Dasilio, K. L., Miguel, G. P. S., Bressan, J., Lemos, E. M., Moysés, M. R., Abreu, G. R., Azevedo, J. L. M. C., de Carvalho, P. S., Passos‐Bueno, M. R. S., et al. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0894-2 · Cited by 78
“These proteins may represent a link between obesity and associated co-morbidities, including cardiovascular diseases, type 2 diabetes, and certain cancers, among other conditions [6–8].”
BackgroundPCR arrays identify metallothionein-3 as a highly hypoxia-inducible gene in human adipocytes
Wang, B., Wood, I. S., & Trayhurn, P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.036 · Cited by 78
β-cell failure in type 2 diabetes mellitus
Lencioni, C., Lupi, R., & Prato, S. D. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0031-0 · Cited by 78
Chang, H. M., Lee, H. J., Park, H. S., Kang, J., Kim, K. S., Song, Y. S., & Jang, Y. J. (2010) · Obesity · doi:10.1038/oby.2010.60 · Cited by 76
“In addition to storing excess energy, adipose tissue secretes several bioactive peptides that exert paracrine and endocrine effects and play an important role in metabolic regulation (3,4).”
BackgroundThe study of anti-metabolic syndrome effect of puerarin in vitro
Xu, M., Xiao, S.-Z., Sun, Y., Zheng, X., Ou-yang, Y., & Chen, G. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.03.036 · Cited by 76
Burgeiro, A., Fuhrmann, A., Cherian, S., Espinoza, D., Jarak, I., Carvalho, R. A., Loureiro, M., Patrício, M., Antunes, M., & Carvalho, E. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00384.2015 · Cited by 76
“Given the importance of inflammation in heart pathophysiology and metabolism, including diabetes (41, 78, 79, 87), we tested the proinflammatory markers IL6, TNFA, IL8, and SERPINE1 gene expression and observed that although there were no differences for IL6 and TNFA, both IL8 and SERPINE1 were significantly decreased…”
MethodCohen, E., Margalit, I., Shochat, T., Goldberg, E., & Krause, I. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s294368 · Cited by 80
A microarray analysis of the hypoxia-induced modulation of gene expression in human adipocytes
Mazzatti, D. J., Lim, F.-L., O'Hara, A., Wood, I. S., & Trayhurn, P. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.654611 · Cited by 74
“The expansion of white adipose tissue mass in obesity induces a state of inflammation in the tissue which is considered to underpin the development of the associated diseases, particularly the metabolic syndrome and type 2 diabetes (Hotamisligil, 2006; Rosen & Spiegelman, 2006; Yudkin, 2003).”
BackgroundImpact of oxygen availability on body weight management
Quintero, P., Milagro, F. I., Campión, J., & Martínez, J. A. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.10.022 · Cited by 74
“On the other hand, obese subjects present a chronic inflammation of the adipose tissue [9], which is potentially considered to play an important role in the initiation and development of obesity-related diseases [10,11], and to enhance the oxidative stress of fat tissue [12–14].”
BackgroundKeller, C. S., Ainsworth, B. E., Records, K. A., Todd, M. W., Belyea, M. J., Vega‐López, S., Permana, P. A., Coonrod, D. V., & Williams, A. N. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-971 · Cited by 79
“Adipose tissue secretion of IL-6 may constitute up to a third of its plasma concentration [34].”
BackgroundWang, P., Wang, S. C., Yang, H.-P., Lv, C., Jia, S., Liu, X., Wang, X., Meng, D., Qin, D., Zhu, H. F., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00454 · Cited by 73
“Other molecules, such as interleukin-6, that affect lipid metabolism (Yudkin, 2003) are associated with increased level of C-reactive protein production, which changes inversely to serum OT levels (Qian et al.”
BackgroundExcessive visceral fat accumulation in advanced chronic obstructive pulmonary disease
Kida, K., Furutate, R., Ishii, I., Wakabayashi, Motegi, Yamada, & Gemma (2011) · International Journal of COPD · doi:10.2147/copd.s22885 · Cited by 73
“C-reactive protein, and interleukin (IL)-6, are particularly associated with central or visceral obesity.(11) Adiponectin is an anti-inflammatory cytokine that is believed to control cardiovascular diseases.”
Morand, J.-P. F., Macri, J., & Adeli, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413343200 · Cited by 70
Wood, I. S., Stezhka, T., & Trayhurn, P. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-0985-7 · Cited by 65
“As adipose tissue mass expands in obesity, an inflammatory response is initiated in the tissue and this is associated both with the increased release of inflammatory adipokines and by the recruitment of macrophages [7, 11, 37, 39, 44].”
BackgroundCirculating IL-18 and the risk of type 2 diabetes in women
Hivert, M., Sun, Q., Shrader, P., Mantzoros, C. S., Meigs, J. B., & Hu, F. B. (2009) · Diabetologia · doi:10.1007/s00125-009-1455-z · Cited by 68
Wu, J. T., & Wu, L. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.10.016 · Cited by 65
Metadata
- Authors
- Yudkin, J. S.
- Affiliations
- University College London (GB)
- Corresponding author
- Yudkin, J S
- ORCID
- Yudkin, J S
- Venue
- International Journal of Obesity
- Published
- 2003-11-14
- Volume
- 27
- Issue
- S3
- Pages
- S25-S28
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W2087706636
- Cited by
- 311
- References
- 0
- Citations by year
- 2025: 1 · 2024: 5 · 2023: 4 · 2022: 8 · 2021: 9 · 2020: 10 · 2019: 14 · 2018: 6 · 2017: 5 · 2016: 9 · 2015: 11 · 2014: 19 · 2013: 17 · 2012: 22
- FWCI
- 15.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- adipose tissue, insulin resistance, abdominal obesity, low-grade inflammation, adipokines, cytokines, TNF-α, interleukin-6, C-reactive protein, fibrinogen, endothelial dysfunction, microalbuminuria, plasminogen activator inhibitor-1, diabetic dyslipidemia, metabolic syndrome, vascular disease
- MeSH terms
- Adipose Tissue, Animals, Endothelium, Vascular, Humans, Inflammation, Insulin Resistance, Vascular Diseases, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
